Literature DB >> 20458398

Efficient in situ three-component formation of chiral oxazoline-Schiff base copper(II) complexes: towards combinatorial library of chiral catalysts for asymmetric Henry reaction.

Wen Yang1, Han Liu, Da-Ming Du.   

Abstract

A combinatorial in situ three-component chiral oxazoline-Schiff base copper(II) complex catalyst formation method was developed. This simple combinatorial chiral catalyst approach provided a modular library of chiral oxazoline-Schiff base copper(II) complex catalysts. The catalytic activity of these in situ generated catalysts can be rapidly and conveniently evaluated in the asymmetric Henry reaction. Moderate to good yields and enantioselectivities (up to 92% ee) were obtained under the optimized condition. The combination of modular three-component catalyst formation and in situ asymmetric reaction provides a new technology in asymmetric catalysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458398     DOI: 10.1039/b923835b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  Fluorescence Titrations of Bio-relevant Complexes with DNA: Synthesis, Structural Investigation, DNA Binding/Cleavage, Antimicrobial and Molecular Docking Studies.

Authors:  Thesingu Rajan Arun; Ramasamy Subramanian; Seemon Packianathan; Natarajan Raman
Journal:  J Fluoresc       Date:  2015-07-07       Impact factor: 2.217

2.  Fabrication of Sb3+ sensor based on 1,1'-(-(naphthalene-2,3-diylbis(azanylylidene))bis(methanylylidene))bis(naphthalen-2-ol)/nafion/glassy carbon electrode assembly by electrochemical approach.

Authors:  Mohammed M Rahman; Tahir Ali Sheikh; Reda M El-Shishtawy; Muhammad Nadeem Arshad; Fatimah A M Al-Zahrani; Abdullah M Asiri
Journal:  RSC Adv       Date:  2018-05-29       Impact factor: 3.361

3.  Cu (II)-catalyzed asymmetric henry reaction with a novel C1-symmetric aminopinane-derived ligand.

Authors:  Liudmila Filippova; Yngve Stenstrøm; Trond Vidar Hansen
Journal:  Molecules       Date:  2015-04-09       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.